Blood Services Clause Samples

Blood Services. This agreement does NOT cover penalty fees related to blood services. This agreement does NOT cover any services for drawing, processing, or storage of your own blood.

Blood Services. Range of services The DHB will ensure the provision of blood, blood products and blood services include, but are not limited to: blood components and plasma-derived products for health services for people administration and transfusion informed consent, including provision of systems to document that the potential recipient has been informed of the benefits and potential risks associated with administration of the blood component or plasma-derived products monitoring the use of blood components and plasma-derived products reporting untoward events and adverse outcomes associated with transfusion to the New Zealand Blood Service (NZBS) Haemovigilance office. The National Haemophilia Management Group (NHMG) is responsible for the management oversight of the coordinated services for people with haemophilia. Each DHB will ensure that recombinant Factor VIII and/or Factor IX products (‘synthetic blood products’) are able to be accessed for haemophilia treatment according to NHMG guidelines on the use of recombinant products in New Zealand. Access Doctors decide on the use of blood components and plasma-derived products in emergencies, and for the treatment of specific conditions like haemophilia and primary immune deficiency. In circumstances where a proposed treatment approach represents a significant move away from usual practice in terms of volume of product, clinical liaison with an NZBS transfusion medicine specialist is recommended.